SICKLE CELL ANEMIA (HBSS)

Clinical trials for SICKLE CELL ANEMIA (HBSS) explained in plain language.

Never miss a new study

Get alerted when new SICKLE CELL ANEMIA (HBSS) trials appear

Sign up with your email to follow new studies for SICKLE CELL ANEMIA (HBSS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New approach to sickle cell treatment aims to protect young organs

Disease control Recruiting now

This study is testing a personalized way to determine the starting dose of hydroxyurea, a standard medication for sickle cell anemia, in young children. Instead of using only weight-based dosing, researchers will use blood tests to understand how each child's body processes the m…

Matched conditions: SICKLE CELL ANEMIA (HBSS)

Phase: PHASE4 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

SICKLE CELL ANEMIA (HBSS)

Get alerted when new SICKLE CELL ANEMIA (HBSS) trials appear

New approach to sickle cell treatment aims to protect young organs